Medicine & pharmacy

BeOne Medicines Launches Following Redomiciliation to Switzerland, Marking a New Chapter in Global Oncology

BeOne well-positioned to deliver transformative treatments to patients worldwide with powerful oncology portfolio, pioneering clinical development approach, and expanded global manufacturing and commercial capabilities Redomiciliation...

US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon HADLIMA™ (adalimumab-bwwd) Injection

HADLIMA™ (adalimumab-bwwd) injection, 40 mg/0.4 mL & 40 mg/0.8 mL is now interchangeable with all high- and low-concentration presentations (autoinjector, prefilled syringe, and single-dose vial)...

Takeda and Nature Announce Call for Applications Now Open for 2026 Innovators in Science Award

− Award supports emerging biomedical researchers globally focused on gastrointestinal and inflammatory diseases, neuroscience and oncology OSAKA, Japan & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Takeda (TSE:4502/NYSE:TAK) today...

TreeFrog Therapeutics Secures €30 Million From European Investment Bank (EIB) Marking a Significant Milestone in the Company’s Journey to Accelerate the Field of Cell Therapy

€30 million financing with mix of dilutive and venture debt financing Funds to advance Parkinson’s disease cell therapy program to the clinic and further develop...

ASCO 2025: REVEAL GENOMICS Unveils New HER2DX Data From 800+ Patients

HER2DX analysis includes data from over 800 patients across four studies in the neoadjuvant (CompassHER2 pCR, BionHER), adjuvant (RESPECT) and metastatic (DFCI) settings. In neoadjuvant...

BeiGene Receives Positive CHMP Opinion for TEVIMBRA® as a First-Line Treatment for Nasopharyngeal Cancer

Positive opinion for TEVIMBRA in combination with chemotherapy as a first-line treatment of nasopharyngeal cancer (NPC) based on results of RATIONALE-309 study demonstrating statistically significant...

RHEACELL and AOP Health: Strategic Partnership to Deliver Breakthrough Therapies for the “Butterfly Children’s Disease” and Chronic Venous Wounds

Partnership aims to provide patients with high unmet medical needs access to innovative cell therapies HEIDELBERG, Germany & VIENNA–(BUSINESS WIRE)– RHEACELL, a German biotech company...

World-Leading Cancer Center, The Royal Marsden NHS Foundation Trust, Using AI to Push Boundaries of Cancer Research With NTT DATA and CARPL.ai

This partnership launches a large-scale, AI-powered service designed to accelerate cancer detection and treatment using medical imaging in the UK’s National Health Service (NHS) The...

Versterking van de lokale industrie: SFI Health™ EMEA zet zich in voor Zuid-Afrikaanse verpakkingsbedrijven

Lokale fabrikant zorgt voor de belangrijkste merken van het verpakkingsbedrijf om een verschil te maken in de gemeenschap: Packed with Care, Packed right Here (Verpakt...

Mitsui Chemicals lanceert nieuw durfkapitaalfonds ‘321Catalyst™’

TOKIO–(BUSINESS WIRE)– Mitsui Chemicals, Inc. (Tokio: 4183; voorzitter & CEO: HASHIMOTO Osamu), een internationale fabrikant van chemicaliën gevestigd in Japan, kondigde vandaag de lancering aan...

Quadria Capital Closes Oversubscribed US$1 Billion Fund III to Advance Healthcare Transformation Across Asia

Fund close exceeds initial target despite a challenging fundraising environment, reflecting strong investor confidence in India and Southeast Asia healthcare Existing investors increased commitment amount...

Mitsui Chemicals Launches New Corporate Venture Capital Fund ‘321Catalyst™’

TOKYO–(BUSINESS WIRE)– Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu), a global chemicals manufacturer based in Japan, today announced the launch of its...

Curatis onthult corticorelin als werkzame stof van C-PTBE-01

De marktmogelijkgeid van corticorelin ter behandeling van peritumoraal heresenoedeem (PTBE) zal naar verwachting meer dan USD 1 miljard bedragen; het team wordt versterkt met Dr....

Het ENDEAVOUR-programma voor longkanker stelt internationale teams samen om vier samenwerkingsprojecten te starten die gericht zijn op het verbeteren van de zorg voor de patiënt

ENDEAVOUR brengt 21 veelbelovende longkankerspecialisten en diverse internationaal erkende experts bijeen om de samenwerking te bevorderen en de uitkomst voor patiënten te verbeteren Driejarige programma...

Curatis discloses Corticorelin as active substance of C-PTBE-01

Corticorelin Market Opportunity in Peritumoral Brain Edema (PTBE) expected to exceed USD 1 billion; Strengthens team with Dr. Kirsty Crame and Dr. Timm Trenktrog LIESTAL,...